Bank of New York Mellon’s EnteroMedics Inc. ETRM Stock Holding History

Bank of New York Mellon’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-94	Closed	-$13K	–	4403
2015 Q4	$13K	Hold	94	–	–	﹤0.01%	4300
2015 Q3	$26K	Hold	94	–	–	﹤0.01%	4303
2015 Q2	$61K	Sell	94 -1	-1%	-$1.15K	﹤0.01%	4144
2015 Q1	$91K	Sell	95 -9	-9%	-$10.9K	﹤0.01%	4062
2014 Q4	$155K	Buy	104 +1	+1%	+$1.35K	﹤0.01%	3956
2014 Q3	$133K	Hold	103	–	–	﹤0.01%	3984
2014 Q2	$169K	Buy	103 +79	+329%	+$148K	﹤0.01%	3877
2014 Q1	$45K	Buy	+24	New	+$56.8K	﹤0.01%	4090

Other funds holding ETRM

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Bank of New York Mellon's ETRM Position: Q1 2016 in Review

Bank of New York Mellon sold out of EnteroMedics Inc. (ETRM) in Q1 2016, closing a stake of 94 shares — an estimated $13K sold.

Bank of New York Mellon first reported a position in ETRM in Q1 2014 and held it in 8 quarters. The position peaked at $169K in Q2 2014. 26 funds tracked by Wall St. Rank hold ETRM as of Q1 2016.

Bank of New York Mellon reported no remaining EnteroMedics Inc. position as of Q1 2016 after selling out during the quarter.
Bank of New York Mellon sold 94 EnteroMedics Inc. shares in Q1 2016, an estimated $13K.
Bank of New York Mellon first reported a position in EnteroMedics Inc. in Q1 2014 and held it in 8 quarters.
Bank of New York Mellon's EnteroMedics Inc. position peaked at $169K in Q2 2014.
26 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2016.

Based on Bank of New York Mellon's 13F filing for Q1 2016, filed 11 May 2016.